L-Valine.
The repair BCAA. Tissue maintenance, nitrogen balance. An essential branched-chain amino acid used as a structural residue in muscle protein and, unlike leucine, as a glucogenic fuel feeding the citric acid cycle.
Reviewed March 2026
- Category
- Amino acid
- Also filed under
- Muscle repairNitrogen balanceRecovery
What L-Valine is, and what it does.
- Does it work
- Suits people in heavy training blocks, eating in a deficit, or eating plant-based. On a high daily protein target, valine largely comes with the food.
- How much to take
- Start with 3g to 6g a day, the maintenance band that keeps the branched-chain pool stocked. Trial protocols have used more as a research condition.
- Time to feel it
- No same-day signal. Valine's contribution shows across weeks of training and eating, in the lean mass you hold, rather than as a sensation after a serving.
- The first dose
- No same-day signal. Blood levels rise within about half an hour, and the contribution sits in amino acid supply for repair.
- With regular use
- Weeks of steady intake keep nitrogen balance and the amino acid pool stocked, so muscle protein has its full set of parts. It reads in maintained lean mass.
- How well tolerated
- Well tolerated at supplement amounts and present in everyday protein. Large amounts can unsettle the stomach. Check with your clinician if you have kidney concerns.
- How it feels
- On its own, not much sensation. Taken around training, people report sessions that feel less draining, and that's a modest effect rather than a lift.
- The overlooked benefit
- Valine is glucogenic. Its carbon skeleton ends as succinyl-CoA and can enter the citric acid cycle or glucose production, which sets it apart from leucine.
3 to 6g a day is where L-Valine works.
Source: Shimomura et al., J Nutr 2006; BCAA ratio guidelines
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Based on 35 human trials and 3 meta-analyses with 65% consistency.
- Dietary indispensability and nitrogen balanceNarrative review
- Muscle protein synthesis as part of branched-chain intakeRandomised trial
- Muscle soreness after hard trainingMeta-analysis
- Perceived exertion during endurance workRandomised trial
- Lean mass retention while eating in a deficitRandomised trial
Questions people ask about L-Valine.
- When should I take it?
- Timing matters less than consistency. Pick a time that works for you and take it daily.
- Should I take it on an empty stomach?
- Most amino acids absorb better on an empty stomach since they don't compete with food proteins for absorption. 30 minutes before meals is ideal.
- Can I get enough from protein?
- If you eat enough protein (0.8-1g per pound bodyweight), you probably get enough aminos. Supplementing specific ones only makes sense for targeted goals.
- Can I take it with other supplements?
- Usually fine. The main thing to watch is not doubling up on the same ingredient from different products. If you're on prescription meds, check with your pharmacist first.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
L-valine and L-leucine move through the same aminotransferase and the same ketoacid dehydrogenase complex, which is why they are formulated together rather than alone. Leucine carries the anabolic signal and valine keeps the branched-chain pool in balance.
Branched-chain aminotransferase needs pyridoxal 5-phosphate to strip the amino group from L-valine. Without adequate B6 that first metabolic step slows regardless of how much valine is supplied.
The isobutyryl-CoA dehydrogenase step downstream of L-valine transamination runs on FAD, which the body builds from riboflavin. Riboflavin status supports the normal handoff of branched-chain carbons into the citric acid cycle.
L-valine and L-tyrosine compete for the same large neutral amino acid transporter at the blood brain barrier. Taking a large branched-chain serving alongside tyrosine reduces how much tyrosine reaches the brain, so spacing them apart is the sensible order.
Valine and leucine are transaminated by the same branched-chain aminotransferase and then handled by one shared ketoacid dehydrogenase complex. Loading leucine alone speeds that complex and draws down valine as well, which is why blends keep them together.
The branched-chain ketoacid dehydrogenase complex that oxidises valine's ketoacid runs on thiamine pyrophosphate. Thiamine status sets the capacity of that step.
The same dehydrogenase complex uses NAD as its terminal electron acceptor. Niacin supplies the NAD that lets valine carbon move on.
Valine oxidation runs through isobutyryl-CoA and further acyl-CoA intermediates, all built on coenzyme A. Pantothenic acid is the precursor of that carrier.
Valine catabolism reaches propionyl-CoA, which is carboxylated by a biotin-dependent enzyme. Biotin availability gates that exit toward the citric acid cycle.
The methylmalonyl-CoA formed from valine is rearranged to succinyl-CoA by a B12-dependent mutase. That final step needs B12 to complete.
The amino group stripped from valine in muscle is passed to glutamate and exported largely as glutamine. The two amino acids sit at either end of that nitrogen handoff.
Branched-chain nitrogen released from valine is also carried out of muscle as alanine through the glucose-alanine cycle. Alanine is the shuttle for that nitrogen.
Valine competes with tryptophan for the large neutral amino acid carrier into the brain, so a valine load lowers central tryptophan delivery. This is the classic branched-chain and tryptophan competition.
Tyrosine crosses into the brain on the same carrier valine uses. High branched-chain doses reduce how much tyrosine gets across.
5-HTP crosses on the large neutral amino acid carrier that valine also occupies. Taking them together lowers 5-HTP entry into central tissue.
Norvaline is valine without its side-chain branch and competes for the same transport. Combining them sets up competition rather than addition.
Valine and isoleucine are both branched-chain amino acids and enter the same catabolic route through branched-chain aminotransferase and the branched-chain alpha-keto acid dehydrogenase complex. Supplying one without the others shifts the competition for those shared enzymes. Blends pair them for that reason, which is formulation convention rather than a measured clinical effect.
Valine and phenylalanine are both large neutral amino acids carried across the intestinal and blood-brain barrier membranes by the LAT1 transport system. A large single dose of one lowers the fraction of the transporter available to the other. This is a transport interaction, not an outcome, and it matters most when the two are taken together on an empty stomach.
Methionine is also a LAT1 substrate, so it shares the same carrier as valine. Co-dosing shifts the relative uptake of each rather than blocking either outright. Spacing the two apart is the usual formulation answer.
Histidine competes with valine for large neutral amino acid transport at the gut and the blood-brain barrier. The practical consequence is a change in the timing and proportion of what arrives, measured as plasma amino acid patterns rather than as a functional endpoint.
The branched-chain alpha-keto acid dehydrogenase complex that oxidises valine's keto acid carries lipoamide on its E2 subunit, the protein-bound form of lipoic acid. Without that cofactor the complex cannot turn over. The relationship is settled enzymology; it is not a claim that supplemental lipoic acid raises valine handling in people.
The thiamine-pyrophosphate-dependent decarboxylation step in valine breakdown requires a divalent magnesium ion at the active site. Magnesium also supports the ATP-dependent kinase and phosphatase pair that switches the complex on and off. Established enzymology, no combination trial implied.
Valine catabolism runs down to propionyl-CoA before entering the citric acid cycle. Carnitine forms esters with short-chain acyl-CoA species, which is how the cell exports surplus acyl groups and frees coenzyme A. The link is a settled metabolic relationship measured as acylcarnitine profiles, a marker rather than an outcome.
Whey already carries a high proportion of branched-chain amino acids including valine, so added free valine sits on top of an existing dose. Brands that stack the two are adding to a background intake rather than introducing something the protein lacks. Read the pairing as a dose question, not a mechanism.
Casein clots in the stomach and releases its amino acids slowly, while free valine appears in plasma quickly. Combining them changes the shape of the appearance curve rather than the total delivered. That is a pharmacokinetic observation, not a performance claim.
HMB is a downstream metabolite of leucine, valine's companion branched-chain amino acid, and the two are routinely formulated into the same muscle-support products. They enter the same branched-chain catabolic machinery upstream. The pairing is formulation convention supported by shared biochemistry.
Creatine and branched-chain amino acids are combined in the same training-support products because they act on different parts of normal muscle function, energy buffering versus substrate supply. No mechanistic interaction between them is established. The pairing is a product convention.
Nothing specific on file for L-Valine. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What L-Valine actually does.
Valine is one of nine amino acids your body can't make, so every bit of it comes from your diet or a supplement.
The first committed step of breaking valine down turns it into alpha-ketoisovalerate, and that enzyme is far busier in your skeletal muscle than in your liver.
Next, that keto acid gets oxidised by an enzyme complex running on thiamine pyrophosphate and lipoamide. All three branched-chain amino acids share it.
Valine is glucogenic. Its carbon skeleton finishes as succinyl-CoA, which can feed the citric acid cycle or glucose production, and that's where it parts ways with leucine.
Where L-Valine comes from.
Most valine in supplements is grown, not mixed. Bacteria are fed plant sugar in a tank, they release valine into the liquid, and the valine is filtered out, purified and dried into a white powder. A chemical route exists too, which is why the paperwork checks that only the L-form is present.
The same molecule is reached more than one way. Which route a given product used is a manufacturing choice, and the finished compound is the same either way.
Refined glucose or sucrose from corn, cassava or sugar cane feeds the fermentation broth, along with an ammonium salt as the nitrogen source.
Selected Corynebacterium glutamicum or Escherichia coli strains, bred or engineered to overflow the branched-chain pathway, secrete L-valine into the broth over several days under controlled oxygen, temperature and pH.
Valine can also be made synthetically, which yields a racemic DL mixture that then needs enzymatic or chemical resolution to isolate the L-isomer used in supplements.
Cells and solids are separated from the liquid by centrifugation and filtration, leaving a valine-rich stream.
The amino acid is captured on ion exchange resin, eluted, then passed over activated carbon to remove pigment and residual broth components.
Concentration and cooling crystallise the L-valine, which is washed, dried and milled to a specified particle size, then assayed for optical purity and residual solvents.
Getting L-Valine from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- Across 25 trials in 479 people, branched-chain amino acids including valine lowered muscle soreness at 24 and 48 hours after hard exercise (standardised mean difference about -0.28 to -0.92) and lowered muscle damage markers at 48 hours, but did not speed the return of muscle performance.Meta-analysis. Doma et al., 2021 (Applied Physiology, Nutrition, and Metabolism). PMID 34612716 ↗
- Pooling eight randomised trials, branched-chain amino acids including valine lowered post-exercise creatine kinase by about 145 U/L at 24 hours, while differences in muscle soreness and lactate dehydrogenase were not statistically detectable.Meta-analysis. Rahimi et al., 2017 (Nutrition). PMID 28870476 ↗
- An umbrella review of 53 meta-analyses of randomised trials rated the evidence for branched-chain amino acids including valine reducing delayed-onset muscle soreness as moderate certainty.Systematic review. Talebi et al., 2024 (Nutrition Reviews). PMID 37460208 ↗
- In a crossover trial with 11 active young men, three days of branched-chain amino acids including valine raised fat oxidation during an hour of steady cycling, raised carbohydrate oxidation and cycling efficiency during a ride to exhaustion, and lowered self-rated fatigue right after exercise.Randomised trial. Luan et al., 2025 (Nutrients). PMID 40219047 ↗
- Across branched-chain amino acid trials, which supply valine, effects on endurance performance were inconsistent and reporting quality was often too poor to draw a firm conclusion.Systematic review. Del Guerra et al., 2026 (The Physician and sportsmedicine). PMID 41655197 ↗
- The authors report that liquid valine and isoleucine preparations were tolerated and accepted by participants on medically supervised protein-restricted diets.Open-label trial. Tosi et al., 2026 (Orphanet Journal of Rare Diseases). PMID 41928300 ↗
- The authors conclude that a high-leucine branched-chain amino acid supplement, which includes valine, lessened the reduction in quadriceps muscle thickness observed over the study period.Randomised trial. Wulandari et al., 2026 (Clinical Nutrition ESPEN). PMID 41325937 ↗
- The authors report that L-valine supplementation altered molecular signalling pathways and increased apoptosis markers in mouse testicular tissue.Animal study. Wu et al., 2024 (Theriogenology). PMID 38000127 ↗
- Adding L-valine to low-nitrogen diets shifted rumen fermentation parameters and predicted methane output in the authors' model.Animal study. Li et al., 2026 (Animals). PMID 41976028 ↗
- Graded valine supplementation was associated with changes in meat metabolite profiles and rumen microbial composition.Animal study. Wang et al., 2026 (Frontiers in Microbiology). PMID 41971336 ↗
- Valine, lysine and threonine combinations influenced alpha-casein synthesis in cultured mammary epithelial cells, with the authors identifying preferred ratios in that system.In vitro study. Yang et al., 2026 (Frontiers in Veterinary Science). PMID 41929274 ↗
These are the studies our verdict leans on, chosen from the 22,056 we read for L-Valine. The full linked list is below.
Problems people have reported.
Read this carefully. These are 94 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular L-Valine is, not how risky it is. A report is not proof L-Valine caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.
